Cite
HARVARD Citation
Ribaldone, D. et al. (2018). Adalimumab trough levels predict Crohn's disease clinical course. Digestive and liver disease. 50 (2), pp. 204-206. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ribaldone, D. et al. (2018). Adalimumab trough levels predict Crohn's disease clinical course. Digestive and liver disease. 50 (2), pp. 204-206. [Online].